应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
AKTX Akari Therapeutics PLC
盘后交易 05-07 18:47:08 EDT
1.45
+0.11
+8.21%
最高
1.49
最低
1.35
成交量
1.24万
今开
1.40
昨收
1.34
日振幅
10.45%
总市值
1,149万
流通市值
692.84万
总股本
792.37万
成交额
1.78万
换手率
0.26%
流通股本
477.82万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Akari Therapeutics Plc盘中异动 股价大涨5.22%
自选股智能写手 · 05-07 22:40
Akari Therapeutics Plc盘中异动 股价大涨5.22%
Akari Therapeutics Plc盘中异动 早盘股价大涨5.49%报1.25美元
自选股智能写手 · 04-29
Akari Therapeutics Plc盘中异动 早盘股价大涨5.49%报1.25美元
加载更多
公司概况
公司名称:
Akari Therapeutics PLC
所属市场:
NASDAQ
上市日期:
--
主营业务:
Akari Therapeutics, Plc是一家生物制药公司,致力于研究非甾体,合成消炎药。塞尔苏斯认为它创造了一类新的合成药物,它称之为多功能较新的多药平台,可广泛治疗炎症性疾病和条件。塞尔苏斯的经营策略是扩大和建立自己的生物制药业务,逐渐集中于一系列炎症性疾病。根据其当前和未来的第一类候选产品,该公司认为它将填补目前未满足的安全和有效的替代类固醇的需要。作为药物开发公司,其大部分精力和资源一直致力于进行开发和研究,开展临床前研究和临床试验,发展和保护自己的知识产权和筹集资金。塞尔苏斯打算就其药品的商业化战略的发牌安排参与制药公司许可证协议。塞尔苏斯还打算继续逐步针对其他类型的炎症疾病扩大其产品范围。该公司于2004年10月7日在英格兰和威尔士注册成立为一家私营有限责任公司。
发行价格:
--
{"stockData":{"symbol":"AKTX","market":"US","secType":"STK","nameCN":"Akari Therapeutics PLC","latestPrice":1.45,"timestamp":1715112000000,"preClose":1.34,"halted":0,"volume":12419,"delay":0,"floatShares":4778209,"shares":7923695,"eps":-2.044748,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.11,"latestTime":"05-07 18:47:08 EDT","open":1.402,"high":1.49,"low":1.35,"amount":17832.761268,"amplitude":0.104478,"askPrice":1.89,"askSize":100,"bidPrice":1.2,"bidSize":10,"shortable":0,"etf":0,"ttmEps":-2.044748,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1715126400000},"adr":1,"adjPreClose":1.34,"adrRate":2000,"preHourTrading":{"tag":"盘前","latestPrice":1.323,"preClose":1.35,"latestTime":"07:41 EDT","volume":33,"amount":43.659,"timestamp":1715082114688},"volumeRatio":0.218427},"requestUrl":"/m/hq/s/AKTX/","defaultTab":"news","newsList":[{"id":"2433789520","title":"Akari Therapeutics Plc盘中异动 股价大涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433789520","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433789520?lang=zh_cn&edition=full","pubTime":"2024-05-07 22:40","pubTimestamp":1715092848,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日22时40分,Akari Therapeutics Plc股票出现异动,股价急速拉升5.22%。截至发稿,该股报1.41美元/股,成交量699股,换手率0.01%,振幅0.00%。Akari Therapeutics Plc股票所在的生物技术行业中,整体涨幅为0.68%。其相关个股中,珐博进、Lexaria Bioscience Corp C/Wts 14/01/2026 、Geovax Labs Inc C/Wts 29/09/2025涨幅较大,Clearmind Medicine Inc.、Tc Biopharm Plc、Allarity Therapeutics, Inc.较为活跃,换手率分别为1385.04%、168.17%、163.94%,振幅较大的相关个股有珐博进、Clearmind Medicine Inc.、Tc Biopharm Plc,振幅分别为41.38%、37.61%、37.16%。Akari Therapeutics Plc公司简介:Akari Therapeutics PLC 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240507224049861eb7e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240507224049861eb7e2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431866734","title":"Akari Therapeutics Plc盘中异动 早盘股价大涨5.49%报1.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431866734","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431866734?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:31","pubTimestamp":1714397518,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日21时31分,Akari Therapeutics Plc股票出现波动,股价急速上涨5.49%。截至发稿,该股报1.25美元/股,成交量101股,换手率0.00%,振幅0.00%。Akari Therapeutics Plc股票所在的生物技术行业中,整体涨幅为0.18%。其相关个股中,Zyversa Therapeutics, Inc.、Soleno Therapeutics, Inc.、Mesoblast Ltd涨幅较大,Zyversa Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Avenue Therapeutics, Inc.较为活跃,换手率分别为413.36%、22.64%、9.67%,振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Zyversa Therapeutics, Inc.、Calcimedica, Inc.,振幅分别为19.05%、13.83%、10.09%。Akari Therapeutics Plc公司简介:Akari Therapeutics PLC 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292131587924ebed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292131587924ebed&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.akaritx.com","stockEarnings":[{"period":"1week","weight":0.047},{"period":"1month","weight":-0.0496},{"period":"3month","weight":-0.4915},{"period":"6month","weight":-0.6193},{"period":"1year","weight":-0.6225},{"period":"ytd","weight":-0.5705}],"compareEarnings":[{"period":"1week","weight":0.0128},{"period":"1month","weight":-0.0036},{"period":"3month","weight":0.0457},{"period":"6month","weight":0.1814},{"period":"1year","weight":0.2519},{"period":"ytd","weight":0.0868}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Akari Therapeutics, Plc是一家生物制药公司,致力于研究非甾体,合成消炎药。塞尔苏斯认为它创造了一类新的合成药物,它称之为多功能较新的多药平台,可广泛治疗炎症性疾病和条件。塞尔苏斯的经营策略是扩大和建立自己的生物制药业务,逐渐集中于一系列炎症性疾病。根据其当前和未来的第一类候选产品,该公司认为它将填补目前未满足的安全和有效的替代类固醇的需要。作为药物开发公司,其大部分精力和资源一直致力于进行开发和研究,开展临床前研究和临床试验,发展和保护自己的知识产权和筹集资金。塞尔苏斯打算就其药品的商业化战略的发牌安排参与制药公司许可证协议。塞尔苏斯还打算继续逐步针对其他类型的炎症疾病扩大其产品范围。该公司于2004年10月7日在英格兰和威尔士注册成立为一家私营有限责任公司。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.038226},{"month":2,"riseRate":0.2,"avgChangeRate":-0.178281},{"month":3,"riseRate":0.363636,"avgChangeRate":0.063354},{"month":4,"riseRate":0.363636,"avgChangeRate":0.043402},{"month":5,"riseRate":0.090909,"avgChangeRate":-0.184966},{"month":6,"riseRate":0.5,"avgChangeRate":0.015536},{"month":7,"riseRate":0.3,"avgChangeRate":-0.002417},{"month":8,"riseRate":0.6,"avgChangeRate":0.304867},{"month":9,"riseRate":0.5,"avgChangeRate":0.046873},{"month":10,"riseRate":0.3,"avgChangeRate":-0.112696},{"month":11,"riseRate":0.5,"avgChangeRate":-0.001754},{"month":12,"riseRate":0.2,"avgChangeRate":-0.076365}],"exchange":"NASDAQ","name":"Akari Therapeutics PLC","nameEN":"Akari Therapeutics PLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Akari Therapeutics PLC(AKTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Akari Therapeutics PLC(AKTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Akari Therapeutics PLC,AKTX,Akari Therapeutics PLC股票,Akari Therapeutics PLC股票老虎,Akari Therapeutics PLC股票老虎国际,Akari Therapeutics PLC行情,Akari Therapeutics PLC股票行情,Akari Therapeutics PLC股价,Akari Therapeutics PLC股市,Akari Therapeutics PLC股票价格,Akari Therapeutics PLC股票交易,Akari Therapeutics PLC股票购买,Akari Therapeutics PLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Akari Therapeutics PLC(AKTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Akari Therapeutics PLC(AKTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}